Cytora Ltd. Appoints Dr. Thomas Serena, MD, World‑Renowned Wound Care Expert to Scientific Advisory Board to Lead Patient Treatment Access and Data Collection f…

Cytora Ltd. ("Cytora"), a clinical-stage biotechnology company developing allogeneic stem cell therapies, today announced the ...
Healio

Novel regimen reduces chronic GVHD after allogeneic stem cell transplantation

Please provide your email address to receive an email when new articles are posted on . The addition of post-transplant cyclophosphamide to sirolimus and cyclosporine reduced chronic GVHD. Efforts are ...
The Brighterside of News on MSN

Study finds low-dose CAR T therapy can drive complete cancer remission

A bone marrow transplant can buy time for people with aggressive B-cell cancers. Too often, it does not buy enough. For ...
ascopubs.org

Targeting exercise and sedentary behavior for the prevention of allogeneic stem cell transplant-related cardiovascular dysfunction: The ALLO-Active trial.

Technology-enhanced palliative care for patients with advanced cancer undergoing phase I therapies: A pilot randomized clinical trial (RCT). Patient reported symptoms after cancer diagnosis and the ...
Targeted Oncology

FDA Clears IND for Off-the-Shelf Treg Therapy CK0802 in Chronic GVHD

Allogeneic HSCT is frequently complicated by acute GVHD (~50%) and chronic GVHD (30%–70%), with steroid-refractory disease representing a major unmet need despite ruxolitinib availability. CK0802 ...
Cure Today

Survivors May Have Successful Pregnancies After Stem Cell Transplants

Contrary to past research, blood cancer survivors may have safe and successful pregnancies up to 10 years after an allogeneic stem cell transplant. Successful and safe pregnancies are possible among ...